Cel AI PLC (LON:CLAI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.280
+0.020 (7.69%)
Feb 21, 2025, 4:20 PM BST
-25.33%
Market Cap 1.57M
Revenue (ttm) 17.94K
Net Income (ttm) -1.83M
Shares Out 602.25M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,719,799
Average Volume 6,127,794
Open 0.247
Previous Close 0.260
Day's Range 0.240 - 0.280
52-Week Range 0.030 - 0.550
Beta -0.34
RSI 57.24
Earnings Date Feb 26, 2025

About Cel AI

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom. [Read more]

Founded 2018
Employees 1
Stock Exchange London Stock Exchange
Ticker Symbol CLAI
Full Company Profile

Financial Performance

In 2024, Cel AI's revenue was 17,942, a decrease of -73.31% compared to the previous year's 67,236. Losses were -1.83 million, -44.79% less than in 2023.

Financial Statements

News

There is no news available yet.